75 related articles for article (PubMed ID: 8190199)
1. Endothelin and vascular reactivity in Bartter's syndrome.
Calò L; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
Nephron; 1994; 66(3):370-1. PubMed ID: 8190199
[No Abstract] [Full Text] [Related]
2. Endothelium-derived vasoactive substances in Bartter's syndrome.
Calò L; Cantaro S; Calabrò A; Piarulli F; Rizzolo M; Favaro S; Antonello A; Crepaldi G; Borsatti A
Angiology; 1995 Oct; 46(10):905-13. PubMed ID: 7486211
[TBL] [Abstract][Full Text] [Related]
3. Intracellular calcium signalling and vascular reactivity in Bartter's syndrome.
Calò L; D'Angelo A; Cantaro S; Rizzolo M; Favaro S; Antonello A; Borsatti A
Nephron; 1996; 72(4):570-3. PubMed ID: 8730423
[TBL] [Abstract][Full Text] [Related]
4. [Elevated atrial natriuretic peptide (ANP) levels and normotension in Bartter's syndrome in childhood].
Di Pietro A; Proverbio MR; Capuano F; Chianese F; Coletta S; Catera P
Pediatr Med Chir; 1993; 15(3):289-90. PubMed ID: 8415177
[TBL] [Abstract][Full Text] [Related]
5. [Bartter's syndrome. Primary renal hyperprostaglandinism].
Smiley JW; Del Guercio ET; March NM; Hornych A
J Urol Nephrol (Paris); 1977 Sep; 83(9):693-9. PubMed ID: 926231
[No Abstract] [Full Text] [Related]
6. The hyperprostaglandin E syndrome: a hypercalciuric variant of Bartter's syndrome.
Welch TR
J Bone Miner Res; 1997 Oct; 12(10):1753-4. PubMed ID: 9333138
[No Abstract] [Full Text] [Related]
7. Functional interpretation of the kidney juxtaglomerular apparatus using renin immunohistochemistry in Bartter's, pseudo-Bartter's and Conn's syndromes.
Lertprasertsuke N; Kakudo K; Osamura Y; Nomoto Y; Sakai H; Watanabe K
Tokai J Exp Clin Med; 1990 Jul; 15(4):317-26. PubMed ID: 2130539
[TBL] [Abstract][Full Text] [Related]
8. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome.
Watanabe S; Fukumoto S; Chang H; Takeuchi Y; Hasegawa Y; Okazaki R; Chikatsu N; Fujita T
Lancet; 2002 Aug; 360(9334):692-4. PubMed ID: 12241879
[TBL] [Abstract][Full Text] [Related]
9. Bartter's syndrome and Gitelman's syndrome: two entities sharing the same abnormality of vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Bonfante L; Favaro S; D'Angelo A
Clin Nephrol; 1998 Jul; 50(1):65-7. PubMed ID: 9710351
[No Abstract] [Full Text] [Related]
10. Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter's and Gordon's syndromes.
Tunny TJ; Gordon RD
Lancet; 1986 Feb; 1(8475):272-3. PubMed ID: 2868281
[No Abstract] [Full Text] [Related]
11. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
[TBL] [Abstract][Full Text] [Related]
12. Bartter's syndrome, hypomagnesaemia and chondrocalcinosis.
de Heide LJ; Birkenhäger JC
Neth J Med; 1991 Oct; 39(3-4):148-52. PubMed ID: 1791876
[TBL] [Abstract][Full Text] [Related]
13. Blood and extracellular fluid volume in patients with Bartter's syndrome.
Boer P; Hené RJ; Koomans HA; Nieuwenhuis MG; Geyskes GG; Mees EJ
Arch Intern Med; 1983 Oct; 143(10):1902-5. PubMed ID: 6625776
[TBL] [Abstract][Full Text] [Related]
14. Increased sodium-lithium countertransport in red cells of patients with Bartter's syndrome.
Mattioli M; Delva P; Lechi C; Minuz P; Lechi A; Scuro LA
J Endocrinol Invest; 1984 Feb; 7(1):61-3. PubMed ID: 6715799
[TBL] [Abstract][Full Text] [Related]
15. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
[TBL] [Abstract][Full Text] [Related]
16. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
[TBL] [Abstract][Full Text] [Related]
17. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
Horký K; Schreiber V; Dvoráková J
Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
[TBL] [Abstract][Full Text] [Related]
18. Platelet calmodulin concentration in essential hypertension and in Bartter's syndrome.
Calò L; Cantaro S; Vianello A; Favaro S; Borsatti A
Am J Nephrol; 1986; 6 Suppl 1():60-2. PubMed ID: 3103446
[No Abstract] [Full Text] [Related]
19. [Bartter's syndrome].
Linnanvuo-Laitinen M; Pirttiaho H; Huttunen K; Viinikka L
Duodecim; 1985; 101(20):1983-6. PubMed ID: 4085359
[No Abstract] [Full Text] [Related]
20. [Bartter's syndrome--hypokalemic renal tubular syndrome].
Gazdíková K; Gazdík F
Cas Lek Cesk; 2003 Aug; 142(8):474-8. PubMed ID: 14626562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
